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PERSPECTIVES ON DRUGS 
Wastewater analysis and drugs: 
a European multi-city study
I  Wastewater testing in European cities
In 2010, a Europe-wide network (Sewage Analysis CORE 
Group — Europe) was established to standardise the 
approach to wastewater analysis and to coordinate national 
studies. Following the success of an initial study in 19 
European cities in 2011 (Thomas et al., 2012), comparable 
studies were undertaken over the following three years 
covering up to 21 European countries. A standard protocol 
and a common quality control exercise were used in all 
locations, which made it possible to directly compare illicit 
drug loads in Europe over a one-week period during four 
consecutive years. (1). Raw 24-hour composite samples 
were collected during a single week and were analysed for 
the urinary biomarkers (i.e. measurable characteristics) of 
the parent drug (i.e. primary substance) for amphetamine, 
methamphetamine and MDMA. In addition, the samples were 
analysed for the main urinary metabolites (i.e. substances 
produced when the body breaks drugs down) of cocaine and 
cannabis, which are benzoylecgonine (BE) and THC-COOH 
(11-nor-9-carboxy-delta9-tetrahydrocannabinol). 
I  Patterns of illicit drug use: geographical and temporal variation  
The project revealed a picture of distinct geographical and 
temporal patterns of drug use across European cities (see 
interactive graphic online). The BE loads observed indicate 
that cocaine use is higher in western and some southern 
European cities and lower in northern and eastern European 
cities. Amphetamine use was found to be relatively evenly 
Wastewater analysis is a rapidly 
developing scientific discipline with 
the potential for monitoring real-time 
population-level trends in illicit drug use. 
Originally used in the 1990s to monitor the 
environmental impact of liquid household 
waste, the method has since been used 
to estimate illicit drug consumption in 
different cities (Daughton, 2001; Zuccato 
et al., 2008; van Nuijs et al., 2011). It 
involves sampling a source of wastewater, 
such as a sewage influent to a wastewater 
treatment plant. This allows scientists to 
estimate the quantity of drugs consumed 
in a community by measuring the levels of 
illicit drugs and their metabolites excreted 

















Full edition of this article with interactive  
features available online at
(1 ) The protocol can be found on the EMCDDA website: www.emcdda.europa.eu/
wastewater-analysis. 
.
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distributed across European cities, although with highest 
levels reported in the north and northwest of Europe. In 
contrast, methamphetamine use is concentrated in cities 
within the Czech Republic, Slovakia and northern Europe, 
while the observed methamphetamine loads in the other 
locations were very low to negligible.
Relatively low levels of the urinary biomarker loads related to 
MDMA were found in most European countries. The highest 
loads found were detected in Dutch cities.
With regard to cannabis, the identification of THC-COOH 
loads in wastewater poses some analytical challenges, and as 
a result not all samples were analysed for this metabolite of 
THC. In contrast to the other illicit drugs under investigation, it 
was not possible to establish regional patterns.
The study also highlighted differences among cities within 
the same country, which may be explained in part by the 
different social and demographic characteristics of the cities 
(universities, existence of nightlife area and age distribution 
of population). In the majority of countries with multiple 
study locations, cocaine and MDMA loads were generally 
higher in large cities compared to towns. No such differences 
could be detected for THC-COOH, amphetamine and 
methamphetamine loads.
In addition to geographical patterns, wastewater analysis 
can detect fluctuations in weekly patterns of illicit drug use. 
In the majority of cities, higher loads of BE and MDMA were 
detected during the weekend (Friday to Monday) than during 
weekdays. In contrast, cannabis and methamphetamine use 
were found to be distributed more evenly over the whole 
week.
A sub-set of cities were involved in the earliest wastewater 
study in 2011, and when these first results are compared 
with data from the three consecutive years a stable picture 
of cocaine use can be observed over time. The general 
patterns detected were similar in all three years, with the 
highest and lowest BE loads found in the same cities and 
regions. In a few cases, in particular in southern and western 
European countries, a decrease in BE loads was observed 
between 2011 and 2013–14. In a few northern European 
cities an increase in BE loads was observed in 2014. For 
methamphetamine, the results showed an increase between 
2011 and 2014 in some cities with low loads detected in 
the first study. Overall, the data related to amphetamine 
and cannabis from the four monitoring campaigns showed 
no major changes in the general patterns of use observed. 
However, some individual cities did show slight increases in 
MDMA loads.
I  Comparison with findings from other monitoring tools
The trends and patterns being detected by wastewater 
analysis are largely, but not completely, in line with the 
analyses coming from other monitoring tools, such as 
surveys, treatment demand and law enforcement data. For 
example, prevalence data from surveys and wastewater 
analysis both present a picture of a geographically divergent 
stimulant market in Europe, where cocaine is more prevalent 
in the south and west, while amphetamines are more 
common in central and northern countries (EMCDDA, 2015). 
Data from established indicators and from wastewater 
also show that methamphetamine use has been primarily 
concentrated in the Czech Republic, but is now also present 
in some other countries (EMCDDA, 2015). Similarly, both 
studies based on self-reported drug use and wastewater 
data point towards the same weekly variations in use, with 
stimulants such as amphetamine and cocaine being primarily 
used at weekend music events and in celebratory contexts 
(Tossmann et al., 2001).
Some differences between wastewater and other indicator 
data can be seen in relation to cannabis and MDMA. In line 
with data from established indicators, wastewater analysis 
revealed high THC-COOH loads in Spanish and some 
Dutch cities. However, while Italy and the Czech Republic 
rank among the high prevalence countries for cannabis, 
wastewater data did not confirm this. The picture for MDMA 
is also unclear. There are indications of a recent resurgence 
of the MDMA market (EMCDDA, 2014), and slight increases 
were also detected in wastewater compared to 2011, but in 
general the MDMA loads detected in wastewater remain low.
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I  Limitations of this method
Wastewater analysis offers an interesting complementary 
data source for monitoring the quantities of illicit drugs used 
at the population level, but it cannot provide information on 
prevalence and frequency of use, route of administration, main 
classes of users and purity of the drugs. Additional challenges 
arise from uncertainties associated with the sampling of 
wastewater, behaviour of the selected biomarkers in the 
sewer, reliability of inter-laboratory analytical measurement, 
different back-calculation methods and different approaches 
to estimate the size of the population being tested (Castiglioni 
et al., 2013b; Lai et al., 2014). The caveats in selecting the 
analytical targets for heroin, for example, make monitoring 
this drug in wastewater more complicated compared 
to other substances. Also, the purity of street products 
fluctuates unpredictably over time and in different locations. 
Furthermore, translating the total consumed amounts into 
the corresponding number of average doses is complicated 
as drugs can be taken by different routes and in amounts that 
vary widely, and purity levels fluctuate (Zuccato et al., 2008).
I New developments and the future
Alongside developments in wastewater analysis at the 
general population level, a new technique has been 
established that involves the collection and analysis of 
pooled urine from stand-alone portable urinals. This method 
can detect both traditional drugs and new psychoactive 
substances, including previously undetected drugs, even at 
low concentrations (Archer et al., 2013a; Archer et al., 2013b; 
Reid et al., 2014).
Wastewater analysis has demonstrated its potential as a 
complement to established monitoring tools in the drugs 
area. It has some clear advantages over other approaches 
as it is not subject to response and non-response bias 
and can better identify the true spectrum of drugs being 
consumed, as users are often unaware of the actual mix 
of substances they take. This tool also has the potential 
to provide timely information in short timeframes on 
geographical and temporal trends, but, as is the case with 
established monitoring tools, this method can be hampered 
by reporting delays. In order to check the quality and accuracy 
of data, further comparisons between wastewater analysis 
and data obtained through other indicators are needed. To 
date, there have been few attempts to compare estimates 
produced from wastewater and more established techniques 
(Bramness et al, 2014; Reid et al., 2012; Thomas et al., 2012). 
Nonetheless, as a method wastewater analysis has moved 
from being an experimental technique to being a new method 
in the epidemiological toolkit. Its rapid ability to detect new 
trends can help target public health programmes and policy 
initiatives at specific groups of people and the different drugs 
they are using.
I  Terms and definitions 
Back-calculation is the process whereby researchers 
calculate/estimate the consumption of illicit drugs in 
the population based on the amounts of the target drug 
residue entering the wastewater treatment plant.
Liquid chromatography–tandem mass spectrometry 
(LC-MS/MS) is the analytical method most commonly 
used to quantify drug residues in wastewater. LC-MS/MS 
is an analytical chemistry technique that combines the 
separation techniques of liquid chromatography with the 
analysis capabilities of mass spectrometry. Considering 
the complexity and the low concentrations expected 
in wastewater, LC-MS/MS is one of the most powerful 
techniques for this analysis, because of its sensitivity and 
selectivity.
Metabolite  Traces of drugs consumed will end up in 
the sewer network either unchanged or as a mixture of 
metabolites. Metabolites, the end products of metabolism, 
are the substances produced when the body breaks drugs 
down. 
Residue  Wastewater analysis is based on the fact that 
we excrete traces in our urine of almost everything we 
consume, including illicit drugs. The target drug residue 
is what remains in the wastewater after excretion and is 
used to quantify the consumption of illicit drugs in the 
population.
Urinary biomarkers  Analytical chemists look for urinary 
biomarkers (measurable characteristics to calculate 
population drug use) in wastewater samples, which can be 
the parent drug (i.e. the primary substance) or its urinary 
metabolites.
Interactive: explore the data from the study, available on the EMCDDA website: 
emcdda.europa.eu/topics/pods/waste-water-analysis
I  Interactive element
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 Wastewater analysis approach
In order to estimate levels of drug use from wastewater, 
researchers attempt first to identify and quantify drug 
residues, and then to back-calculate the amount of the 
illicit drugs used by the population served by the sewage 
treatment plants (Castiglioni et al., 2013a). This approach 
involves several steps (see figure). Initially, composite 
samples of untreated wastewater are collected from the 
sewers in a defined geographical area. The samples are 
then analysed to identify concentrations of the target drug 
residues. Following this, the drug use is estimated through 
back-calculation by multiplying the concentration of each 
target drug residue (ng/L) with the corresponding flow of 
sewage (L/day). A correction factor for each drug is taken 
into account as part of the calculation. In a last step, the 
result is divided by the population served by the wastewater 
treatment plant, which shows the amount of a substance 
consumed per day per 1 000 inhabitants. Population 
estimates can be calculated using different biological 
parameters, census data, number of house connections, or 
the design capacity, but the overall variability of different 
estimates is generally very high. 
Although primarily used to study trends in illicit drug 
consumption in the general population, wastewater analysis 
has also been applied to small communities, including 
workplaces, schools, music festivals, prisons and specific 
neighbourhoods.  
 
Using this method in small communities can involve ethical 
risks (Prichard et al., 2014), such as possible identification 
of a particular group within the community. Consequently, 
there is a strong need for ethical guidelines for researchers 
using this technique (Hall et al., 2012). Ideally these 
guidelines should be interdisciplinary and international and 
should entail some consideration of how findings might be 
interpreted, how media outlets might misrepresent findings 
and how policymakers may respond (Prichard et al., 2014).   






2. Sample analysis to obtain the 
concentrations of the target residues
1. Sample collection
(composite 24-h samples)
6. Amount of substance as doses/day/1 000 inhabitants
5. Normalisation of the amount of substance
to a dened population (g or mg/day/1 000 inhabitants)
4. Amount of a substance consumed by the 
population served by the treatment plant 
3. Amount of target residues entering
the treatment plant (g/day)
Source: (Castiglioni et al., 2013a)
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